Effectiveness of Hsp90 Inhibitors as Anti-Cancer Drugs

E-ISSN： 1875-5607|6|10|1137-1143

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.6, Iss.10, 2006-10, pp. : 1137-1143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Possible Effects of Early Treatments of Hsp90 Inhibitors on Preventing the Evolution of Drug Resistance to Other Anti-Cancer Drugs

Current Medicinal Chemistry, Vol. 14, Iss. 2, 2007-01 ,pp. : 223-232

Bentham Science Publishers

Access to resources Recommend Favorite

Hsp90 Inhibitors as Anti-Cancer Agents, from Basic Discoveries to Clinical Development

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 366-376

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of HSP90 and other chaperones for the treatment of cancer

By Dymock Brian W Drysdale Martin J McDonald Edward Workman Paul

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 6, 2004-06 ,pp. : 837-847

Informa Healthcare

Access to resources Recommend Favorite

Ansamycin Inhibitors of Hsp90: Nature's Prototype for Anti-Chaperone Therapy

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 15, 2009-11 ,pp. : 1386-1418

Bentham Science Publishers

Access to resources Recommend Favorite

Macrocyclic Inhibitors of Hsp90

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1380-1402

Bentham Science Publishers

Access to resources Recommend Favorite